CHEMORESISTANCE TO NEOADJUVANT CHEMOTHERAPY IN YOUNG PATIENTS WITH ER-POSITIVE BREAST CANCER

被引：0
|
作者：
Moon, B. [1 ]
Seoh, J. [2 ]
Woo, J. [1 ]
Lim, W. [1 ]
机构：
[1] Ewha Womans Univ Mokdong Hosp, Seoul, South Korea
[2] Ewha Womans Univ Sch Med, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu328.17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
348P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant endocrine therapy vs chemotherapy for postmenopausal ER-positive breast cancer patients
    Semiglazov, VF
    Ivanov, VG
    Semiglazov, VV
    Ziltsova, EK
    Keltzel, AA
    Melnikova, OA
    Topuzov, EE
    Paltuev, RM
    Bozhok, AA
    Dashian, GA
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S106 - S107
  • [2] The neoadjuvant endocrinetherapy vs chemotherapy in postmenopausal woment with ER-positive breast cancer
    Semiglazov, V. F.
    Semiglazov, V. V.
    Ivanov, V. G.
    Zhiltzova, E. R.
    Kletsel, A. E.
    Dashyan, G. A.
    Bozhok, A. A.
    Paltuev, R. M.
    Berstein, L. M.
    Krivorotko, R. V.
    BREAST, 2007, 16 : S50 - S50
  • [3] PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
    Ohara, Ako Matsushita
    Naoi, Yasuto
    Shimazu, Kenzo
    Kagara, Naofumi
    Shimoda, Masafumi
    Tanei, Tomonori
    Miyake, Tomohiro
    Kim, Seung Jin
    Noguchi, Shinzaburo
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (03) : 533 - 543
  • [4] PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
    Ako Matsushita Ohara
    Yasuto Naoi
    Kenzo Shimazu
    Naofumi Kagara
    Masafumi Shimoda
    Tomonori Tanei
    Tomohiro Miyake
    Seung Jin Kim
    Shinzaburo Noguchi
    Breast Cancer Research and Treatment, 2019, 173 : 533 - 543
  • [5] Neoadjuvant chemotherapy in ER-positive Early Breast Cancer: predictive factors of response and outcome
    Kouadri, N.
    Boudersa, A.
    Bouguetaya, A.
    Djedi, H.
    BREAST, 2023, 68 : S65 - S65
  • [6] Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study
    Joohyun Woo
    Se Jeong Oh
    Jeong-Yoon Song
    Byung Joo Chae
    Jung Eun Choi
    Jeeyeon Lee
    Heung Kyu Park
    Woosung Lim
    BMC Cancer, 21
  • [7] Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study
    Woo, Joohyun
    Oh, Se Jeong
    Song, Jeong-Yoon
    Chae, Byung Joo
    Choi, Jung Eun
    Lee, Jeeyeon
    Park, Heung Kyu
    Lim, Woosungf
    BMC CANCER, 2021, 21 (01)
  • [8] Neoadjuvant therapy for ER-positive breast cancers
    Colleoni, M.
    Montagna, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 243 - 248
  • [9] Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer
    Li-Tong Yao
    Mo-Zhi Wang
    Meng-Shen Wang
    Xue-Ting Yu
    Jing-Yi Guo
    Tie Sun
    Xin-Yan Li
    Ying-Ying Xu
    World Journal of Clinical Cases, 2019, (15) : 1937 - 1953
  • [10] Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer
    Yao, Li-Tong
    Wang, Mo-Zhi
    Wang, Meng-Shen
    Yu, Xue-Ting
    Guo, Jing-Yi
    Sun, Tie
    Li, Xin-Yan
    Xu, Ying-Ying
    WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (15) : 1937 - 1953
12345